Valeo Financial Advisors, LLC - ANGION BIOMEDICA CORP ownership

ANGION BIOMEDICA CORP's ticker is ANGN and the CUSIP is 03476J107. A total of 44 filers reported holding ANGION BIOMEDICA CORP in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Valeo Financial Advisors, LLC ownership history of ANGION BIOMEDICA CORP
ValueSharesWeighting
Q1 2023$21,432
-28.5%
36,9510.0%0.00%
-50.0%
Q4 2022$29,989
-49.2%
36,951
-42.0%
0.00%
-50.0%
Q3 2022$59,000
-19.2%
63,6590.0%0.00%
-20.0%
Q2 2022$73,000
-45.9%
63,6590.0%0.01%
-28.6%
Q1 2022$135,000
+95.7%
63,659
+169.2%
0.01%
+75.0%
Q4 2021$69,000
-81.1%
23,651
-36.8%
0.00%
-81.0%
Q3 2021$365,00037,4000.02%
Other shareholders
ANGION BIOMEDICA CORP shareholders Q2 2022
NameSharesValueWeighting ↓
CM Management, LLC 600,000$552,0000.62%
Nantahala Capital Management 1,066,012$981,0000.06%
BVF INC/IL 1,071,297$986,0000.04%
Birchview Capital, LP 54,392$50,0000.04%
Park West Asset Management LLC 370,724$341,0000.02%
Cannell Capital 40,181$37,0000.01%
Patriot Financial Group Insurance Agency, LLC 36,500$34,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 175,000$161,0000.00%
Valeo Financial Advisors, LLC 63,659$59,0000.00%
Ergoteles LLC 78,857$73,0000.00%
View complete list of ANGION BIOMEDICA CORP shareholders